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Abstract. Collagen IV is a major structural component 
of all basal laminae (BLs). Six collagen IV ot chains are 
present in mammals; or1 and a2(IV) are broadly ex- 
pressed in embryos and adults, whereas ~3-6(IV) are 
restricted to a defined subset of BLs. In the glomerular 
BL of the kidney, the etl and ot2(IV) chains are re- 
placed by the ot3-5(IV) chains as development pro- 
ceeds. In humans, mutation of the collagen or3, or4, or 
et5(IV) chain genes results in a delayed onset renal dis- 
ease called Alport syndrome. We show here that mice 
lacking collagen ot3(IV) display a renal phenotype 
strikingly similar to Alport syndrome: decreased glo- 
merular filtration (leading to uremia), compromised 
glomerular integrity (leading to proteinuria), structural 
changes in glomerular BL, and glomerulonephritis. In- 
terestingly, numerous changes in the molecular compo- 
sition of glomerular BL precede the onset of renal dys- 
function; these include loss of collagens or4 and ct5(IV), 
retention of collagen al/2(IV), appearance of fibronec- 
tin and collagen VI, and increased levels of perlecan. 
We suggest that these alterations contribute, along with 
loss of collagen IV isoforms per se, to renal pathology. 
C 
OLLAGEN IV is a major component of basal laminae 
(BLs)  1 in vertebrates and invertebrates.  Its com- 
ponent polypeptides, called o~ chains, contain long 
"collagenous" stretches of Gly-x-y repeats that form triple 
helical trimers. The trimers, in turn, are covalently joined 
to each other at their "noncollagenous" NH2- and COOH- 
terminal  domains,  forming  a  three-dimensional  lattice 
that contributes importantly to the structural stability of 
the BL. In addition, collagen IV is linked to laminin,  which 
forms the other major BL network, by the bridging glyco- 
protein entactin/nidogen.  Together,  the collagen IV and 
laminin networks are thought to determine the major fea- 
tures  of the  macromolecular  architecture  of BLs.  Both 
laminin  and collagen IV interact with cellular receptors, in- 
cluding the integrins,  thereby playing roles in the adhesion 
of cells to matrix and in signaling from matrix to cells (for 
reviews see Hudson et al., 1993; Yurchenco and O'Rear, 
1994; Kuhn, 1994; Zhou and Reeders, 1996). 
Consistent with these crucial roles, mutations of either 
of the two collagen IV genes in Caenorhabditis elegans are 
embryonically lethal (Guo et al., 1991; Sibley et al., 1994). 
In vertebrates, in contrast, the situation is more complex. 
Mammalian BLs contain six known type IV collagen et chains 
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(Hostikka et al., 1990; Hudson et al., 1993; Ninomiya et al., 
1995; Zhou and Reeders, 1996). Most BLs are rich in al 
and  et2 chains,  suggesting  that  these chains  may be re- 
quired for embryonic development. The ot3-6(IV) chains, 
however, are selectively expressed in small subsets of BLs 
and  are  activated relatively late  in  development.  Thus, 
their  loss might  be expected to cause tissue-specific de- 
fects. Indeed, mutations of the a3-5(IV) genes in humans 
have been associated with Alport syndrome, a hereditary 
glomerulonephritis (inflammation of the kidney glomeru- 
lus) that leads to end-stage renal disease (Barker et al., 
1990; Kashtan  and  Michael,  1993; Kashtan  et  al.,  1994; 
Lemmink et al.,  1994; Mochizuki et al.,  1994; Antignac, 
1995; Kawai et al., 1996; Tryggvason, 1996). Likewise, the 
a5(IV) gene is mutated in a canine model of Alport syn- 
drome (Zheng et al., 1994). 
Analysis of these spontaneously occurring mutants has 
confirmed the importance  of the collagens  IV in verte- 
brates, but lack of a practical animal model has made it 
difficult to answer new questions that  have arisen.  How 
does the loss of collagen IV chains affect the structure and 
function of BLs? Why is renal function normal at birth in 
Alport syndrome, although  collagens et3-5(IV)  are nor- 
mally present in renal BLs perinatally? Are there pheno- 
typic abnormalities  associated with loss of collagen a3--5(IV) 
from other BLs in which they are normally expressed, 
such as those of the testis (Enders et al., 1995), lung (Gun- 
war et al., 1991), or skeletal neuromuscular junction (Sanes 
et al., 1990)? As a first step in addressing these issues, we 
recently cloned cDNAs encoding the ot3-5(IV) chains  in 
mouse and generated subunit-specific antisera to recom- 
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that the distribution of the al-5(IV) chains in mice is simi- 
lar (but not identical) to that in humans (Miner and Sanes, 
1994). Here, we describe the generation and characteriza- 
tion of mutant mice deficient in collagen a3(IV). We docu- 
ment  hereditary  glomerulonephritis  in  these  mice  and 
show that fundamental alterations in the composition of 
renal BLs precede detectable renal pathology. Thus, alter- 
ations in matrix composition resulting from the absence of 
collagen a3(IV) may influence the pathogenesis of Alport 
syndrome. 
Materials and Methods 
Generation of  Mutant Mice 
A h clone containing the 3' end of the Col4a3 gene was obtained by prob- 
ing a 129sv mouse genomic library (Stratagene, La Jolla, CA) with a previ- 
ously described collagen a3(IV) eDNA (Miner and Sanes, 1994). The tar- 
geting vector (see Fig. 1 a) replaced two consecutive AvrII fragments of 
Col4a3, which contain the fast three NC1 domain exons, with a neo cassette 
from the vector pPNT (Tybulewicz et al., 1991). The mutated gene was 
transferred to R1 ES cells (Nagy et al., 1993) by electroporation, and ho- 
mologous recombinants were isolated by double selection with G418 (400 
p,g/mt) and 1-[2'-deoxy-2'-fluoro-13D-arabino  furanosyl] 5' iodo uracil (FIAU) 
(0.27 I~M). The targeting frequency was 1 in 17. Chimeras from three in- 
dependently derived ES clones gave rise to heterozygous and then ho- 
mozygous mutants. The phenotypes of the three lines were indistinguish- 
able, and results from all three have been combined for presentation here. 
Molecular Analyses 
For Southern analysis, genomic DNA from adult tail or liver was digested 
with PstI and probed with a 32p-labeled BamHI fragment of the Col4a3 
genomic clone. The probe lies outside the genomic sequences in the tar- 
geting vector (Fig. 1 a), and thereby provides a stringent test of homolo- 
gous recombination. 
RNase protection analysis was performed using probes and methods 
described  (Miner and Sanes,  1994).  Based  on the assumption that the 
abundance of EFlct RNA varies little among tissues or with age, the level 
of this RNA was assayed in each sample and used to correct for possible 
variation in RNA  amounts or purity.  Relative RNA levels were deter- 
mined by scanning laser densitometry of autoradiograms using an LKB 
Ultroscan (Pharmacia LKB Biotechnology, Inc., Piscataway, NJ). 
Samples of blood and urine were collected from deeply anesthetized 
mice immediately before sacrifice. Total urinary protein was assayed with 
the Bio-Rad Protein Assay reagent (Hercules, CA) according to the man- 
ufacturer's instructions, using BSA as a standard. SDS-gel electrophoresis 
was performed  under reducing conditions in 12%  polyacrylamide  gels; 
protein was visualized with Coomassie blue. Levels of creatinine and urea 
nitrogen in serum and urine were measured with a Cobas Mira Plus ana- 
lyzer (Roche, Somerville, N J). 
Histology 
Methods for light and electron microscopy are described in Noakes et al. 
(1995b).  Antibodies to collagens ct3-5(IV),  laminin-1, laminin 132, col- 
lagens I and VI, and neural cell adhesion molecule (N-CAM) were gener- 
ated in our laboratory (Sanes et al., 1990; Miner and Sanes, 1994; Noakes et 
al., 1995a,b). Several antibodies were gifts of generous colleagues: antiper- 
lecan (HK102 and HK84) from K. Kimata (Nagoya University, Nagoya, 
Japan) and M. Yamagata (National Institute for Basic Biology, Okazaki, 
Japan)  (Kato et al.,  1988), antilaminin 131 (5A2) from D.  Abrahamson 
(University of Alabama at Birmingham) (Abrahamson et al., 1989), anti- 
entactin  from  A.  Chung  (University  of  Pittsburgh,  Pittsburgh,  PA) 
(Bender et al., 1981), antiintegrin et2 (MA2) from S. Santoro (Washington 
University, St. Louis, MO) (Wu and Santoro, 1994), antiintegrin ct3 from 
R. Hynes (Massachusetts Institute of Technology, Cambridge, MA) (De- 
Persio et al., 1995), antiintegrin ct7 from S. Kaufman (University of Illi- 
nois, Urbana, IL) (Martin et al., 1996), and antitenascin (578) from M. 
Schachner  (Swiss  Federal  Inst.  of  Technology,  Zurich,  Switzerland) 
(Gatchalian et al., 1989). Commercial sources for other antibodies were 
Southern Biotechnology Associates, Birmingham, AL (collagen cd/2[IV]), 
Chemicon Intl., Temecula, CA (laminin ~tl), Collaborative Research, Inc., 
Waltham, MA (fibronectin), Novocastra, Newcastle upon Tyne, UK (dys- 
troglycan), and Serotec Ltd., Oxford, U.K. (integrin a6). 
Results 
To mutate the collagen et3(IV) gene (Col4a3), we deleted 
the first three coding exons of the COOH-terminal non- 
collagenous (NC1) domain (Fig. 1 a). This mutation was 
chosen because the NC1 domain is essential for assembly 
of a collagen IV network (Yurchenco and O'Rear, 1994; 
Ries et al., 1995; Zhou and Reeders, 1996) and because a 
similar mutation in the human COL4A5  gene leads to a 
severe form of Alport syndrome (Tryggvason, 1996). The 
targeting vector was transferred to embryonic stem (ES) 
cells by electroporation, homologous recombinants were 
identified, and three independently derived ES cell clones 
generated germline  chimeras  after injection into mouse 
blastocysts. Heterozygotes displayed no detectable abnor- 
malities and produced homozygotes at the expected Men- 
delian  frequency.  Southern  analysis  of  genomic  DNA 
from homozygotes confirmed  disruption  of the  Co14a3 
gene (Fig. 1 b). As expected, no immunoreactivity was de- 
tected in any tissue with antisera to the NC1  domain of 
collagen et3(IV)  (see  below).  Probes  that recognize the 
NH2-terminal portion of the protein or the 5' end of the 
mRNA are  unavailable for mouse, so we  do not know 
whether truncated protein is produced. Studies of other 
collagens have shown, however, that any collagen chains 
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Figure  1.  Mutation  of  the 
Col4a3  gene.  (a)  Structure 
of  the  collagen  a3(IV)  pro- 
tein and targeting vector, and 
the predicted  product  of ho- 
mologous  recombination. 
The  protein  contains  a  cen- 
tral triple helical collagenous 
region  and  a  COOH-termi- 
nal  noncollagenous  (NC1) 
domain, which is essential for 
BL assembly. Three  exons of 
the  NC1  domain  were  de- 
leted in the targeting vector. (b) Southern blot analysis of PstI-digested genomic DNA. The probe, which was from outside the short arm, 
is indicated in a. The 3.9-kb band present in wild-type mice was altered to 2.9 kb in the mutant. 
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(Prockop, 1992). 
Renal Failure in Collagen cO(IV) Mutant Mice 
Homozygous  Co14a3 mutants  were  externally  normal  at 
birth and for ~2  mo thereafter.  At 2-3  mo of age, how- 
ever, most homozygotes began to lose weight and became 
lethargic.  Many  died  in  the  third  postnatal  month,  and 
only ~5% lived longer than 4 mo. Based on the prominent 
glomerulonephritis  in  patient's  with  Alport  syndrome, 
we suspected that renal failure was largely responsible for 
the  mutants'  phenotype.  Indeed,  mutant  kidneys  were 
shrunken, wrinkled, and discolored compared to those of 
heterozygous littermates at >P65 (Fig. 2, c and d). Histo- 
logical confirmation of glomerulonephritis  is detailed be- 
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low.  In  contrast,  kidneys  were  externally  normal  in  ~<5- 
wk-old mutants (Fig. 2, a and b) and displayed only minor 
histological  abnormalities  (Fig.  2,  e  and  f).  Thus,  the 
Col4a3 mutant resembles  humans with  Alport syndrome 
in displaying delayed onset renal disease. 
To  determine  whether  the  renal  abnormality  was  ac- 
companied by impaired renal function, we measured urea 
and creatinine levels in blood and urine (Yager and Har- 
rington,  1995).  Urea  and  creatinine  are  produced  in  tis- 
sues,  dissolved  in  blood,  and  passed  nonselectively 
through the glomerular filter. Decreased glomerular func- 
tion thereby leads to increased levels of both metabolites 
in the serum. In control mice, blood urea nitrogen (BUN) 
and creatinine levels changed little between postnatal days 
(P)20 and 120 (Fig. 3, a and b). Levels of both compounds 
were  normal  in  mutants  until  ,-.~P60 and  then  increased 
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Figure 2.  Morphology and histology of collagen a3(IV)--deficient  kidneys. (a--d) Kidneys from homozygous mutant mice (b and d) and 
littermate controls (a and c) at F36 (a and b) and P103 (c and d). Mutant kidneys are externally normal at P36 but shrunken and mottled at 
P103. (e-j) Periodic acid Schiff-stained sections from mutant (f, h, and j) and control (e, g, and i) kidneys at P36 (e and f) and P79 (g-j). 
Renal histology is nearly normal at P36, but glomerulosclerosis  (h, arrowheads in j), glomerular crescents (C), an expanded interstitium, 
proteinaceous glomerular deposits (arrow in h), tubular deposits (j), and tubular atrophy are evident at P79. Bar in j: (e-h) 50 Ixm; (i and j) 
i00 lxm. 
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Moreover, urinary volume was increased and urea nitro- 
gen and creatinine concentrations in urine were decreased 
relative to controls (data not shown), which may indicate 
failure to concentrate the urine (a tubular function) as well 
as impaired filtration (a glomerular function; Yager and 
Harrington,  1995).  Interestingly,  a  minority of mutants 
maintained normal levels of urea and creatinine in their 
blood as late as P100 (Fig. 3, a and b), and their kidneys 
showed correspondingly mild pathology (data not shown). 
In general, the mice with the most severe histological ab- 
normalities  displayed the  most  severe  uremia  and  pro- 
teinuria. This correlation was evident both as a function of 
age and when comparing mice at a single age. Thus, although 
loss of collagen (x3(IV) always led to renal failure, the rate of 
appearance and the severity of the defect were variable. 
Because the glomerular filter is freely permeable to urea 
and creatinine, their levels primarily reflect filtration ca- 
pacity but not the integrity of the filter. To test the latter, 
we analyzed urine for the presence of protein, which is 
normally excluded from the urinary space by the glomeru- 
lar BL and the cells that abut it. Levels of urinary protein 
were normalized to urinary creatinine to account for po- 
tential  differences in  the  degree  to  which  samples  had 
been concentrated by the kidney. Until P40, mutant pro- 
tein/creatinine ratios were only slightly higher than con- 
trois, but at later ages they were elevated from 2- to >20- 
fold (Fig. 3 c). Oddly, however, hematuria, a cardinal sign 
of Alport and other glomerulonephritides, was not evident 
in  the  Co14a3 mutant.  Therefore, to  confirm that  pro- 
teinuria reflected glomerular failure, we analyzed urinary 
protein by gel electrophoresis. When intact, the glomeru- 
lar filter acts as a barrier to large proteins, such as albu- 
min,  whereas  the  predominant  urinary  proteins  are  of 
lower molecular weight in rare cases of tubular failure to 
resorb  protein  (Carlson  and  Harrington,  1993).  As  ex- 
pected, the  major protein in mutant  urine was  albumin 
(Fig. 3 d), confirming that the glomerular filter had been 
breached. 
Molecular Consequences  of Collagen a3(IV) Deficiency 
Collagens a3-5(IV)  are present in renal BLs soon after 
birth (Miner and Sanes, 1994), yet we were unable to de- 
tect renal defects in the Col4a3 mutant until after P40. Mo- 
lecular alterations that precede overt pathology might pro- 
vide  insights  into  the  role  of  collagen  ct3(IV)  in  BL 
assembly, BL-cell interactions,  and  the  pathogenesis  of 
Alport syndrome. Accordingly, we stained kidneys from 
P15-30 mutants and littermate controls with a panel of an- 
tibodies to BL and plasma membrane components. 
First, we assayed the collagen IV chains. As expected, 
collagen vt3(IV) was  prominent in the BLs of glomeruli 
and of most tubules in controls but was undetectable in 
mutant BLs (Fig. 4, a  and b).  Collagens or4 and ct5(IV) 
were codistributed with collagen et3(IV) in controls but 
undetectable in mutants (Fig. 4, c and d, and Table I). In 
contrast, the collagen ctl/ot2(IV) chains were nearly absent 
from control glomerular BL, but readily detectable in the 
mutant  (Fig. 4, e and f). Thus, disruption of the Co14a3 
gene leads to alterations in the complement of collagen IV 
chains found in both glomerular and tubular BLs. 
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Figure 3.  Analysis of serum and urine. (a) Creatinine concentra- 
tion in serum. (b) BUN concentration. (c) Protein levels in urine, 
normalized for urinary creatinine to correct for differences in de- 
gree of urine concentration. Relative levels of urinary protein are 
similar in mutants and controls until ,~P40, then rise many-fold in 
mutants; levels of serum creatinine and BUN do not rise appre- 
ciably in mutants until after P60. Blood and urine were collected 
from anesthetized mice immediately before sacrifice. Each point 
represents  a single mouse.  (d) SDS-gel  electrophoresis  reveals 
that the major urinary protein in mutants is albumin, indicative of 
a defective glomerular barrier. 
Changes in collagen IV immunoreactivity could reflect 
alterations at any of several levels, from transcription to 
chain assembly. To begin to distinguish these alternatives, 
we used an RNase protection assay to determine the levels 
of collagen etl, a4, and ot5(IV) mRNAs in control and mu- 
tant kidneys (Fig. 5). Collagen al(IV) mRNA levels were 
similar  in  mutant  and  wild-type  animals  at  P28-40,  al- 
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or4 and orS(IV) mRNAs were slightly elevated in mutants 
at all ages, indicating that the absence of these chains from 
mutant  BLs  reflects  regulation  at  a  posttranscriptional 
level. 
Further  immunohistochemical  analysis  revealed  three 
unexpected changes in the composition of glomerular BL 
in the mutant. First, levels of a heparan sulfate proteogly- 
can,  perlecan  (Couchman  et  al.,  1993),  were  greatly  in- 
creased  in  mutant  glomerular  BL;  in  controls,  perlecan 
was present but concentrated in the mesangium (Fig. 4, g 
and h). Similar results were  obtained with two indepen- 
dently isolated  antibodies  (see  Materials  and Methods), 
indicating that this alteration was more likely to reflect an 
increase in the level of perlecan than increased accessibil- 
ity of an epitope. Second, fibronectin was abundant in the 
mesangium of control glomeruli, but absent from the BL 
of peripheral capillary loops (Laitinen et al., 1991). In mu- 
tants, in contrast, fibronectin was present at similar levels 
in BL and mesangium (Fig. 4, i and j). Similarly, collagen 
VI  was  restricted  to  mesangium  in  control  glomeruli 
(Kashtan and Kim,  1992) but was  also detectable  in the 
glomerular BL of mutants (data not shown). 
In contrast to these alterations,  the distribution of the 
major noncollagenous proteins of BLs, laminin, and entac- 
tin did not differ detectably between control and mutant 
kidneys (Fig. 4, k and l, and Table I). Moreover, the sub- 
unit composition of laminin was similar in controls (Sanes 
et al., 1990; Miner and Sanes, 1994) and mutants: tubular 
Figure  4.  Immunohistochemical  analysis  of  kidneys  in  mutants 
(right)  and littermate controls (left) at stages before renal pathology 
is  evident.  (a-/)  P30  sections  were  stained  with  antibodies  to 
collagen ct3(IV) (a and b), collagen ct4(IV) (c and d), collagen al/ 
2(IV)  (e and f), perlecan  (g and h), fibronectin  (i and j), or lami- 
nin 131 (k and/).  Collagens a3-5(IV)  are absent from both glomer- 
uli (G)  and tubules  in mutant kidneys.  Collagen  etl/2(IV),  perle- 
can,  and  fibronectin  are  all  concentrated  in  the  mesangium  of 
normal glomeruli but become prominent in glomerular BL in mu- 
tants.  (m  and n) P3 sections  stained  for  laminin ~/1.  Glomerulo- 
genesis  occurs normally  in the mutant.  G, glomerulus.  Bar in b: 
(a-/) 50 ~m; (m and n) 100 p.m. 
Table L Distribution  of  Matrix and Membrane Antigens  in the 
Kidneys of Control and Col4a3 Mutant Mice 
Component  G  M  T  I  C 
Basal lamina 
Collagen a I/2(IV)  -  + +  + + +  + + + 
~3(IV)  4- -  -  * -  - 
et4(IV)  +  -  -  *  -  - 
~5(IV)  + - -  *- - 
Laminin-1  +++  +++  +++ 
131  --_ +  +++  +++ 
[32  +++ 
~/1  +++  +++  +++ 
Entactin  +++  +++  +++ 
Perlecan  _+ + +  + + +  + + + 
Matrix 
Collagen I 
V  +-4--4- 
VI  --*  +++ 
Tenascin  + + + 
Fibroneetin  -  + +  + + + 
Membrane 
Integrin  et2 
a3  +++  *++ 
e~6  +++  +_* 
a7 
Dystroglycan 
NCAM 
++-4- 
-z-_z+ 
+-4-+ 
--2+ 
+++ 
--+ 
+ 
+ 
+ 
+ 
+ 
+ 
+ 
n 
w 
+ 
m 
m 
+ 
G, glomerular BL or abutting cell membranes; M, mesangmm; T, tubular BL or abut- 
ring membranes; L interstitium; C, glomerular crescents. For each set of three entries, 
the first is from P15-66 control, the second from P30--35 mutant, and the third from 
P66-75 mutant. Crescents were present only in mutants at >P30.  +  or -  denotes 
presence or absence of staining, respectively; +  denotes dim staining; * denotes that 
only a subset was +. Note that integrin et2 and dystroglycan are present in developing 
nephrons (Wu and Santoro,  1993; Durbeej et al., 1995). 
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Figure 5.  Ribonuclease protection analysis of collagen IV chain 
gene expression in kidneys from mutants and littermate controls. 
(a) Representative experiment showing levels of collagen al and 
a4(IV) RNA in heterozygous and homozygous mutant kidney at 
P28 and 78. (b) Ratio of RNA abundance in mutant kidney to 
that in littermate control as a function of postnatal age. Levels of 
et4 and et5(IV) RNA are slightly elevated in mutants at all ages, 
whereas levels of al (IV) RNA increase progressively as renal pa- 
thology worsens. 
and glomerular BLs were rich in the ~/1 chain, tubular BL 
contained 131  but no 132 chain, and glomerular BL con- 
tained 132 but little 131 chain (Table 1). Likewise, both mu- 
tant and control glomerular BL were rich in the recently 
described  laminin o~5  chain  (Miner  et  al.,  1995),  as  re- 
vealed with an antiserum to a  recombinant a5 fragment 
(Miner, J.H., and J.R. Sanes, manuscript in preparation). 
In addition, the distribution and apparent levels of major 
cell surface receptors for BL components (Korhonen et al., 
1990; Patey et al., 1994; Durbeej et al., 1995) were similar 
in mutants and controls; components examined included 
the collagen IV- and laminin-binding integrin subunits et2, 
et3, et6, and a7 and the nonintegrin laminin receptor, dys- 
troglyean (Table I). Thus, the alterations in the molecular 
architecture of mutant glomeruli are profound but selective. 
Finally, we examined early postnatal kidneys in which 
nephrons were still forming. In the developing wild-type 
nephron, glomerular BL is initially rich in collagen al and 
a2(IV) and laminin 131, but these chains are joined by and 
eventually replaced by the collagen ot3--5(IV) and laminin 
132 chains, respectively, as glomerulogenesis proceeds. Tu- 
bular BL is al,2(IV)-positive and mostly et3-5(IV)-nega- 
tive at birth, but a3-5(IV) appears in a subset of tubules 
during the first postnatal weeks. However, in contrast to 
glomerular BL, tubular BL remains strongly al,2(IV)-pos- 
itive into adulthood (Miner and Sanes, 1994).  Based on 
these patterns of expression, it seemed possible that devel- 
opment of tubules or glomeruli might be perturbed or de- 
layed in the mutant. However, no defects were detected in 
mutant P3 kidneys, which contain glomerull and tubules at 
various stages of development (Fig. 4, m  and n). More- 
over, the molecular transition from laminin 131 to 132 oc- 
curred on schedule in mutant glomerular BL (not shown). 
Thus, the appearance of the collagen a3-5(IV) chains ac- 
companies but is not required for key events in the devel- 
opment of the nephron. 
Pathological Consequences of Collagen a3-5(II0 Loss 
At P40, a few glomeruli in mutant kidneys were subtly ab- 
normal  by  conventional  histological  criteria:  they con- 
tained restricted segments of thickened Bowman's capsule 
(crescents)  and/or patches of thickened, closed capillary 
loops (segmental glomerulosclerosis). Both the number of 
glomeruli  affected  and  the  severity  of  the  defects  in- 
creased during the subsequent 4-6 wk. During the same 
period, some tubules atrophied and others dilated, cells 
and extracellular matrix accumulated in interstitial spaces 
between tubules, and many tubules and glomerular capil- 
laries became filled with hyalin deposits (Figs. 2, g-j, and 
6, a and b). By P65, mutant kidneys displayed many signs 
of  chronic  glomerulonephritis  (Kashtan  and  Michael, 
1993; Kashtan et al., 1994). 
Although several distinct human glomerulonephritides 
are  similar  by  light  microscopic  criteria,  glomeruli  in 
Alport syndrome display a distinctive ultrastructural sign: 
the presence of a  thickened, filamentous BL, which has 
been referred to as a "basket weave" (Kashtan and Michael, 
1993; Kashtan et al., 1994). Numerous segments of glomer- 
ular BL in Col4a3 mutant mice displayed a basket-weave 
appearance by F60 (Fig. 7).  Although its etiology is not 
understood, this ultrastructural alteration provides strong 
evidence that the structural consequences of collagen a3- 
5(IV) deficiency are similar in mice and humans. 
The sclerotic glomeruli and expanded tubulointerstitial 
spaces that appeared in the mutant contained increased 
levels of several matrix proteins. Glomeruli accumulated 
collagen etl/2(IV), laminins 131, 132, and ~/1, entactin, and 
perlecan.  Expanded  interstitial  spaces  accumulated col- 
lagen V and tenascin, which were sparse in normal kidney 
(Kashtan and Kim, 1992; Truong et al., 1994), as well as 
collagens I and VI and fibronectin, which were present in 
both control and mutant interstitia (Fig. 6, a-d, and Table I). 
Consistent with the expansion of the collagen ctl(IV)-rich 
matrix, the abundance of collagen etl(IV) RNA increased 
severalfold in mutant kidney between NP40 and P99 (Fig. 
5 b). On the other hand, no significant changes in the com- 
position of mutant BL in nonsclerotic glomeruli were de- 
tected  by  immunohistochemistry between  P15  and  the 
time that renal disease became severe (Table I). 
A  surprising observation was the accumulation of two 
membrane-associated adhesive proteins, N-CAM and in- 
tegrin a6, in the mutant renal cortex. N-CAM was con- 
fined to Bowman's capsule in normal kidney, as reported 
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mutants  (right) and littermate controls  (left) 
at stages when renal pathology is evident. (a-h) 
P60-80 sections were stained with antibodies 
to entactin (a and b), tenascin (c and d), N-CAM 
(e and f), or integrin a6 (g and h). Matrix in 
sclerotic glomeruli is entactin-positive. Cellu- 
lar crescent in f (arrows) is N-CAM-positive. 
Interstitial  deposits between tubules  contain 
tenascin-, N-CAM-, and integrin et6--positive 
components. Integrin et6 is also abundant on 
the basal surfaces of a subset of tubules.  (i) 
P30 section from a mutant, stained for N-CAM. 
N-CAM is present in early glomerular  cres- 
cents (arrowheads) even when most glomeruli 
appear normal. Thus, it serves as a sensitive 
indicator of early glomerular  pathology.  G, 
glomerulus; I, interstitium. Bar, 50 ixm. 
previously (Klein et al., 1988), but was enriched in the cel- 
lular crescents that formed during the initial stage of glo- 
merulonephritis (Fig. 6, e and JO. The presence of N-CAM 
on these cells, along with their localization, suggests that 
they were derived from the parietal epithelial cells that 
comprise Bowman's  capsule.  Moreover, the  paucity of 
N-CAM in normal kidney and its expression in crescents 
provided a useful marker for the relatively rare abnormal 
glomeruli at early stages (Fig. 6 i). Integrin et6 was present 
at low levels on the basal side of all tubules in control kid- 
ney (Korhonen et al., 1990; Patey et al., 1994) but accumu- 
lated to high levels on the basolateral membranes of some 
tubules in the mutant (Fig. 6, g and h). Perhaps physiologi- 
cal changes that lead to or accompany tubular alterations 
in  chronic nephritis  cause up-regulation  of this  integrin 
subunit. Finally, some of the cells in the interstitial spaces 
in the mutant kidneys were labeled by antibodies to inte- 
grin or6 and N-CAM (Fig. 6, e-h). Double-labeling experi- 
ments revealed that the integrin et6- and N-CAM-positive 
interstitial cells were distinct (data not shown), suggesting 
the accumulation of at least two different populations of 
cells in the interstitium. 
Extrarenal Consequences of Collagen a3-5(IV) Loss 
Collagen et3(IV) is present in several nonrenal BLs, in- 
cluding those of cochlea, testis, lung, and skeletal neuro- 
muscular junction. Immunohistochemical analyses of some 
of these tissues revealed two distinct patterns of collagen 
IV chain accumulation in the Col4a3 mutant. First, alveo- 
Miner and Sanes Renal  Failure in a Collagen a3(  lV) Mutant  1409 Figure 7.  Electron micrographs of glomerular BL in P66 control 
(a) and mutant (b) kidneys. The basket-weaving that character- 
izes glomerular BL in humans with Alport syndrome is apparent 
in the mutant.  Arrows indicate glomerular BL. RBC, red blood 
cell. Bar, 0.5 ixm. 
lar BL in lung and seminfferous tubular BL in testis resem- 
ble  tubular BL in kidney in  that  they normally contain 
od,2(IV) as well as ot3-5(IV) chains (Gunwar et al., 1991; 
Enders et al., 1995). The ct3-5(IV) chains were all absent 
from these tissues in the mutant, but the M,2(IV) chains 
persisted (Fig. 8, c and d, and data not shown). Thus, in 
these tissues, as in kidney, assembly or maintenance of the 
a4 and o~5(IV) chains in BLs is dependent on the presence 
of intact et3(IV) chain, consistent with the idea that they 
occur in the same collagen IV network. Second, the BL of 
the  neuromuscular junction in wild-type skeletal muscle 
resembles renal glomerular BL in that it contains the ot3-- 
5(IV) chains, but not M2(IV)  (Sanes et al.,  1990;  Miner 
and Sanes, 1994). No ot3(IV) was detectable at mutant syn- 
apses (data not shown), but o~5(IV) persisted at these sites 
(Fig. 8, a and b). Thus, loss of ot3(IV) does not inevitably 
lead to loss of ot5(IV), perhaps because they are present in 
distinct collagen IV networks in some tissues.  (Because 
antisera to et4(IV) reacted poorly with mouse synapses, we 
could not assess the distribution of this chain.) 
No alterations in gross structure were detected in extra- 
renal  tissues  by  conventional histological  methods,  nor 
were their functions detectably impaired. Matings of Co14a3 
mutant homozygous males and females to wild-type mice 
or to each other gave rise to litters of normal size. We ob- 
served no impairment  of pulmonary function in  Co14a3 
mutants, despite the abundance of collagen ot3-5(IV) RNA 
and protein in normal lung (Gunwar et al.,  1991; Miner 
and  Sanes,  1994).  Initial ultrastructural and immunohis- 
tochemical analyses of neuromuscular junctions (see Noakes 
et al., 1995a, for methods) revealed no abnormalities; electro- 
physiological studies to seek subtle defects are in progress. 
Finally, since sensorineural deafness frequently accom- 
panies Alport syndrome (Kashtan et al., 1994; Wester et al., 
1995), we examined auditory function by recording audi- 
tory brainstem responses to clicks and tone pips (Colvin 
Figure 8.  Distribution of collagen IV chains in extrarenal tissues of 
the collagen ~.3(IV) mutant mouse (b and d) and littermate con- 
trois (a and c). Sections from mnsele (a and b) were stained with 
antiserum to collagen ct5(IV), and sections from testes (c and d) 
were stained with antieollagen a4(IV). The sections from muscle 
were counterstained  with a lectin  (VVA) that marks  synaptic 
sites (a'and b'). Collagen a5(IV) is absent from mutant testes 
(not shown) but persists at mutant neuromuscular junctions. Bar, 
25 l~m. 
et al., 1996) from homozygotes and littermate controls. In 
3 of 12 pairs of mice studied, auditory thresholds were sig- 
nificantly higher in the mutant than in the control. For the 
other nine mutants, however, thresholds and sensitivities 
were within the normal range. Importantly, auditory sensi- 
tivity was normal in mutants studied at P89 and P96, when 
renal pathology was already severe (Bohne, B.A., G.W. 
Harding, J.H. Miner, and J.R. Sanes, unpublished observa- 
tions). These results suggest that cochlear manifestations 
of collagen ct3(IV) loss might depend on strain-dependent 
modifier genes, as has been observed for several heritable 
forms of deafness in mice and humans (Li and Borg, 1991). 
We  are  now testing this possibility by backcrossing the 
Col4a3 mutant allele into various inbred backgrounds. 
Discussion 
Mutation of the Col4a3 gene in mice led to delayed-onset, 
progressive renal disease that includes decreased glomeru- 
lar filtration (resulting in uremia) and increased glomeru- 
lar permeability (resulting in proteinuria). By light micro- 
scopic criteria, the kidneys displayed glomerulosclerosis, 
tubular atrophy, and accumulation of interstitial cells and 
extracellular matrix. Electron microscopy revealed a char- 
acteristic basket-weave thickening and lamellation of the 
glomerular BL.  In  all  of these  respects,  Col4a3  mutant 
mice resemble humans with Alport syndrome (Barker et al., 
1990;  Kashtan  and  Michael,  1993;  Kashtan  et  al.,  1994; 
Lemmink et al.,  1994;  Mochizuki et al.,  1994; Antignac, 
1995; Kawai et al., 1996; Tryggvason, 1996). 
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changes that precede, and might therefore contribute to, 
renal pathology. We found that loss of collagen ot3(IV) led 
to several changes in the composition of glomerular BL, 
some of which were apparent by P15, weeks before histo- 
logical or physiological changes were observed. These in- 
clude  absence  of collagens a4(IV)  and  ot5(IV)  and  in- 
creased levels of collagens ctl,2(IV), fibronectin, perlecan, 
and  collagen VI.  Some  of these  alterations  have  been 
noted previously in human Alport syndrome (Kleppel et 
al., 1987; Kashtan and Kim, 1992; Gubler et al., 1995), but 
it has not been clear whether their appearance preceded 
clinical manifestations of disease. Our observation that the 
molecular composition of glomerular BL is altered in nu- 
merous ways before renal function is detectably impaired 
raises the possibility that these changes, as well as loss of 
collagen et3-5(IV)  per  se, contribute to renal failure in 
Alport syndrome. 
The  first histological abnormality observed  was  the 
appearance of glomerular crescents, visible in a small per- 
centage of glomeruli by P30. Such crescents are not com- 
mon in Alport syndrome but have been described repeat- 
edly (see Gregory and Atkins, 1993 for references). N-CAM, 
which is normally confined to Bowman's capsule in adult 
kidney (Klein et al., 1988),  was present on the cells that 
formed the crescents, consistent with their apparent deri- 
vation from the parietal epithelium of Bowman's capsule. 
Thus, N-CAM may serve as a useful early marker of com- 
promised glomeruli. 
Starting at around P60, levels of serum creatinine and 
blood urea nitrogen began to increase. These changes sig- 
naled a critical decrease in glomerular filtration, which be- 
came progressively more severe, culminating in renal fail- 
ure and death. Histologically, glomerular BL acquired a 
basket-weave appearance, glomeruli became sclerotic, and 
the N-CAM-positive crescentic cells were replaced by de- 
posits of matrix. The occlusion of Bowman's space and of 
glomerular capillaries and the fragmentation of glomeru- 
lar BL are presumably the proximate causes of reduced fil- 
tration rate and selectivity, respectively. Tubular involve- 
ment was also apparent in late stages of the disease. Many 
tubules atrophied, while others became dilated with pro- 
tein deposits. Integrin et6 levels increased markedly in a 
subset of tubules. Interstitial spaces between tubules ex- 
panded and became filled with cells and extracellular ma- 
trix. In human Alport syndrome, interstitial fibrosis pre- 
dominates, but cellular accumulation has also been described 
(Kashtan et al., 1994). 
This sequence of events leads to a speculative model of 
how the Col4a3 mutation leads to renal disease. We pro- 
pose that in glomerular BL, the absence of full-length col- 
lagen et3(IV) prevents the assembly of the collagen or4 and 
a5(IV) chains into a collagen IV network, leading to the de- 
gradation of these chains (Prockop,  1992).  The collagen 
otl,2(IV) network that appears during glomerular develop- 
ment remains as part of the mature glomerular BL, thereby 
compensating structurally for loss of et3-5(IV). However, 
fundamental differences between collagen od,2(IV)  and 
et3-5(IV) networks lead to accumulation of supranormal 
levels of perlecan and ectopic fibronectin and collagen VI in 
the glomerular BL. The changed BL composition results 
in glomerulopathy. The tubular involvement we observed 
may be a nonspecific response to chronic glomerular dis- 
ease or may result from the lack of the collagen ct3-5(IV) 
chains in the subset of proximal and distal tubular BLs, 
where they are normally found. Another possibility, sug- 
gested by the accumulation of cells in the interstitium, is 
that an immune response might contribute to progression 
of the disease. 
The  glomerular structure  and  function in  the  Col4a3 
mutant contrast greatly with those in a mutant that lacks 
another major component of glomerular BL, laminin 132 
(Noakes et al.,  1995a,b).  Perinatally, glomerular BL un- 
dergoes a developmental transition from a preponderance 
of laminin 131 and collagen ctl/2(IV) to a preponderance of 
laminin  132  and  collagen  ct3-5(IV)  (Miner  and  Sanes, 
1994).  In the Col4a3 mutant, the ctl and or2 chains com- 
pensated for the loss of ct3-5(IV), but the laminin 131-132 
transition  clearly occurred.  We  showed  previously that 
laminin 131  levels remain high in the  glomerular BL of 
laminin 132 mutants but that the transition in collagen IV 
chains  occurs  on  schedule  (Noakes  et  al.,  1995b).  To- 
gether, these results demonstrate that the isoform compo- 
sition of the two major macromolecular networks of the 
BL, the collagens IV and the laminins, are regulated inde- 
pendently.  Moreover,  the  mutant  phenotypes  are  ex- 
tremely different. The laminin [32 mutant exhibits massive 
proteinuria at 1-2 wk of age, but this occurs in the absence 
of severe histological change in the kidney. This pattern of 
impaired function with minimally altered structure is remi- 
niscent of minimal change nephrotic syndrome in humans 
(Olson, 1992). In contrast, the Col4a3 mutant exhibits de- 
layed-onset  renal  disease  characterized  by  glomerUlar 
structural  abnormalities  and  interstitial  fibrosis;  this  is 
strikingly similar to the pathology of human Alport syn- 
drome. 
The distinct phenotypes of laminin and collagen IV mu- 
tations indicate that these molecules play distinct roles in 
the glomerulus. We suggest that laminin 132 is a signaling 
molecule that influences the maturation or maintenance of 
the podocyte. In its absence, podocyte differentation is im- 
paired, and the glomerular filtration barrier does not ma- 
ture properly. In contrast, the collagen ct3-5(IV)  chains 
appear to be important for the structural integrity of the 
mature glomerular BL. Thus, loss of the collagen chains 
leads to a significant change in the molecular architecture 
and to the eventual breakdown of the glomerular BL. 
There is, however, an alternative view of both mutant 
phenotypes: perhaps it is neither the absence of the nor- 
mal adult isoform nor the persistence of the fetal isoform 
that leads to renal dysfunction, but rather the generation 
of an incompatible "mismatch" between laminins and col- 
lagens IV. Thus, in the laminin 132 mutant, a fetal 131-con- 
taining  laminin  network  is  associated  with  the  normal 
adult collagen et3-5(IV) network, whereas in the collagen 
et3(IV) mutant, a fetal collagen etl/2(IV) network coexists 
with the normal 132-containing laminin network. If such in- 
compatibility leads to disease, we would expect that dou- 
ble mutants lacking both laminin 132 and collagen et3(IV), 
which would have a fully fetal (laminin 131- and collagen 
otl/2(IV)-containing) glomerular BL, might have a less se- 
vere phenotype than either single mutant. In contrast, if 
laminin 132 and the collagen et3-5(IV) chains play distinct 
roles, then the double mutants would exhibit a more se- 
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testing these ideas. 
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